Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 1/20 | 0.41 |
| ▸ | CDK2 | P24941 | 5/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.39 |
| ▸ | GPR39 | O43194 | 1/20 | 0.39 |
| ▸ | PPARG | P37231 | 1/20 | 0.39 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | AKT1 | P31749 | 2/20 | 0.38 |
| ▸ | AKT2 | P31751 | 2/20 | 0.38 |
| ▸ | AKT3 | Q9Y243 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.38 |
| ▸ | GRK2 | P25098 | 1/20 | 0.38 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.38 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13288676 | 0.83 | CDK2 (0.49) | GSK3BCDK2GPR39PPARGMEN1 | |
| SCHEMBL12954348 | 0.81 | HDAC1 (0.46) | GSK3BCDK2HDAC1PPARGMEN1 | |
| SCHEMBL14418842 | 0.81 | KDM1A (0.43) | GSK3BCDK2HDAC1AKT1AKT2 | |
| SCHEMBL14613366 | 0.79 | KDM1A (0.41) | GSK3BCDK2HDAC1GPR39ALDH1A1 | |
| SCHEMBL13288712 | 0.78 | CDK2 (0.50) | GSK3BCDK2MEN1KMT2ANPC1 | |
| SCHEMBL13288882 | 0.78 | CDK2 (0.54) | GSK3BCDK2HDAC1 | |
| SCHEMBL13288769 | 0.78 | CDK2 (0.55) | GSK3BCDK2MEN1KMT2ANPC1 | |
| SCHEMBL13288668 | 0.78 | CDK2 (0.55) | GSK3BCDK2PPARGMEN1KMT2A | |
| SCHEMBL13288768 | 0.77 | CDK2 (0.54) | GSK3BCDK2HDAC1MEN1KMT2A | |
| SCHEMBL13289714 | 0.76 | EPHX2 (0.47) | GSK3BCDK2ROCK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2194058-A1 | Pyrazolopyrimidines suitable for the treatment of cancer diseases | SCHERING CORPORATION (US) | 2010-06-09 | — | — | EP | disclosed |